Saveria Mazzara

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Heteroplasmic variants of mitochondrial genome in tumor and normal samples from patients with hematologic malignancies.

Heteroplasmic variants of mitochondrial genome in tumor and normal samples from patients with hematologic malignancies.

Journal: Leukemia

Published: March 03, 2026

Targeting DNA interstrand crosslinks repair with synthetic lethality in High-Grade B-Cell Lymphoma.

Targeting DNA interstrand crosslinks repair with synthetic lethality in High-Grade B-Cell Lymphoma.

Journal: Leukemia

Published: September 10, 2025

Single cell RNAseq signatures refined with combiroc enhance identification of NK cells in blood and solid tissues.

Single cell RNAseq signatures refined with combiroc enhance identification of NK cells in blood and solid tissues.

Journal: Scientific reports

Published: June 22, 2025

A human CAGinSTEM platform for decoding HTT repeats' somatic instability links CAG interruption to HD pathology in neurons.

A human CAGinSTEM platform for decoding HTT repeats' somatic instability links CAG interruption to HD pathology in neurons.

Journal: Cell reports

Published: May 13, 2025

Downregulation of rRNA synthesis by BCL-2 induces chemoresistance in diffuse large B cell lymphoma.

Downregulation of rRNA synthesis by BCL-2 induces chemoresistance in diffuse large B cell lymphoma.

Journal: iScience

Published: August 19, 2024

HSP and CD279 gene expression as candidate biomarkers in symptomatic LGLL patients.

HSP and CD279 gene expression as candidate biomarkers in symptomatic LGLL patients.

Journal: Discover oncology

Published: August 09, 2024

A five-gene signature may associate with central nervous system dissemination in adult acute lymphoblastic leukemia.

A five-gene signature may associate with central nervous system dissemination in adult acute lymphoblastic leukemia.

Journal: Hematological oncology

Published: April 05, 2023

[18 F]-FDG PET radiomic model as prognostic biomarker in diffuse large B-cell lymphoma.

[18 F]-FDG PET radiomic model as prognostic biomarker in diffuse large B-cell lymphoma.

Journal: Hematological oncology

Published: August 26, 2022

Predictors of fulvestrant long-term benefit in hormone receptor-positive/HER2 negative advanced breast cancer.

Predictors of fulvestrant long-term benefit in hormone receptor-positive/HER2 negative advanced breast cancer.

Journal: Scientific reports

Published: May 09, 2022

NR1H3 (LXRα) is associated with pro-inflammatory macrophages, predicts survival and suggests potential therapeutic rationales in diffuse large b-cell lymphoma.

NR1H3 (LXRα) is associated with pro-inflammatory macrophages, predicts survival and suggests potential therapeutic rationales in diffuse large b-cell lymphoma.

Journal: Hematological oncology

Published: May 05, 2022

Gene expression profiling and FDG-PET radiomics uncover radiometabolic signatures associated with outcome in DLBCL.

Gene expression profiling and FDG-PET radiomics uncover radiometabolic signatures associated with outcome in DLBCL.

Journal: Blood advances

Published: April 25, 2022

TOSCA: an automated Tumor Only Somatic CAlling workflow for somatic mutation detection without matched normal samples.

TOSCA: an automated Tumor Only Somatic CAlling workflow for somatic mutation detection without matched normal samples.

Journal: Bioinformatics advances

Published: April 08, 2022

Showing 1-12 of 30

Last Updated: 09/26/2026